Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature.

Vasileiοs PergialiotisIoanna Myrto SotiropoulouEfstathia LiatsouMichalis LiontosMaximos FrountzasNikolaos ThomakosAlexandros RodolakisDimitrios Haidopoulos

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

Despite the significant heterogeneity in outcome reporting, the findings of this study reveal the significant benefit of combined platinum taxane chemotherapy on the QoL of ovarian cancer patients and can be used for patients counseling in order to reduce refusals that arise from fear of adverse effects that may negatively affect QoL. Graphical abstract.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
single cell
locally advanced
chronic kidney disease
emergency department
metastatic breast cancer
genome wide
squamous cell carcinoma
patient reported outcomes
adverse drug
rectal cancer
antiretroviral therapy
prefrontal cortex